The global COVID-19 Rapid Antigen Test market size in 2023 is 6028.6 million US dollars, and it is expected to be 9492.1 million US dollars by 2030, with a compound annual growth rate of 6.7% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the COVID-19 Rapid Antigen Test market include Abbott, Cipla, AMEDA Labordiagnostik GmbH, Becton Dickinson, and Beijing Lepu Medical Technology. The share of the top 3 players in the COVID-19 Rapid Antigen Test market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of COVID-19 Rapid Antigen Test market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Nasopharyngeal Swab accounted for XX% of COVID-19 Rapid Antigen Test market in 2023. Oropharyngeal Swab share of XX%.
Hospitals accounted for XX% of the COVID-19 Rapid Antigen Test market in 2023. Diagnostic Laboratories accounts for XX%.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global COVID-19 Rapid Antigen Test Market dynamics, structure by identifying and analyzing the market segments and project the global market size.
In addition, the market SWOT analysis, dynamics, trends, technologies, opportunities and challenges analysis are covered in the report.
Further, the report also focuses on the competitive analysis of key players by product, financial position, product portfolio, growth strategies, and regional presence.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, application, and regional division, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analysis of the competitive environment of COVID-19 Rapid Antigen Test market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and expansion in recent years.
Chapter 3: Analyzes the main companies in the COVID-19 Rapid Antigen Test industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapters 4-6: Segmented the global COVID-19 Rapid Antigen Test market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-10: Provide Americas, Europe, Asia-Pacific and Middle East & Africa COVID-19 Rapid Antigen Test market country segmentation data.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapters 12-14: Provide detailed COVID-19 Rapid Antigen Test market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 15: The main points and conclusions of the report.
Chapter 16: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
Americas
United States
Canada
Brazil
Argentina
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
MEA
Saudi Arabia
UAE
Turkey
Player list
Abbott
Cipla
AMEDA Labordiagnostik GmbH
Becton Dickinson
Beijing Lepu Medical Technology
BIOSYNEX SWISS SA
CerTest Biotect S.L.
Hangzhou Clongene Biotech
Healgen Scientific Limited
LumiraDX UK Ltd.
Quidel Corporation
SD BIOSENSOR, Inc.
Roche
Siemens Healthineers
Xiamen Boson Biotech Co.
Zhejiang Orient Gene Biotech Co., Ltd.
Types list
Nasopharyngeal Swab
Oropharyngeal Swab
Nasal Swab
Application list
Hospitals
Diagnostic Laboratories
Clinics
Homecare
Others
Table of Content
1 Study Coverage
1.1 COVID-19 Rapid Antigen Test Product Introduction
1.2 Market by Type
1.2.1 Global COVID-19 Rapid Antigen Test Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global COVID-19 Rapid Antigen Test Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global COVID-19 Rapid Antigen Test Market by Region
1.4.1 Global COVID-19 Rapid Antigen Test Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global COVID-19 Rapid Antigen Test Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global COVID-19 Rapid Antigen Test Revenue by Players
2.1.1 Global COVID-19 Rapid Antigen Test Revenue by Players (2019-2024)
2.1.2 Global COVID-19 Rapid Antigen Test Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by COVID-19 Rapid Antigen Test Revenue in 2024
2.2 Global COVID-19 Rapid Antigen Test Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global COVID-19 Rapid Antigen Test Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Abbott
3.1.1 Abbott Information
3.1.2 Abbott Overview
3.1.3 Abbott COVID-19 Rapid Antigen Test Revenue and Gross Margin (2019-2024)
3.1.4 Abbott Related Developments
3.2 Cipla
3.2.1 Cipla Information
3.2.2 Cipla Overview
3.2.3 Cipla COVID-19 Rapid Antigen Test Revenue and Gross Margin (2019-2024)
3.2.4 Cipla Related Developments
3.3 AMEDA Labordiagnostik GmbH
3.3.1 AMEDA Labordiagnostik GmbH Information
3.3.2 AMEDA Labordiagnostik GmbH Overview
3.3.3 AMEDA Labordiagnostik GmbH COVID-19 Rapid Antigen Test Revenue and Gross Margin (2019-2024)
3.3.4 AMEDA Labordiagnostik GmbH Related Developments
3.4 Becton Dickinson
3.4.1 Becton Dickinson Information
3.4.2 Becton Dickinson Overview
3.4.3 Becton Dickinson COVID-19 Rapid Antigen Test Revenue and Gross Margin (2019-2024)
3.4.4 Becton Dickinson Related Developments
3.5 Beijing Lepu Medical Technology
3.5.1 Beijing Lepu Medical Technology Information
3.5.2 Beijing Lepu Medical Technology Overview
3.5.3 Beijing Lepu Medical Technology COVID-19 Rapid Antigen Test Revenue and Gross Margin (2019-2024)
3.5.4 Beijing Lepu Medical Technology Related Developments
3.6 BIOSYNEX SWISS SA
3.6.1 BIOSYNEX SWISS SA Information
3.6.2 BIOSYNEX SWISS SA Overview
3.6.3 BIOSYNEX SWISS SA COVID-19 Rapid Antigen Test Revenue and Gross Margin (2019-2024)
3.6.4 BIOSYNEX SWISS SA Related Developments
3.7 CerTest Biotect S.L.
3.7.1 CerTest Biotect S.L. Information
3.7.2 CerTest Biotect S.L. Overview
3.7.3 CerTest Biotect S.L. COVID-19 Rapid Antigen Test Revenue and Gross Margin (2019-2024)
3.7.4 CerTest Biotect S.L. Related Developments
3.8 Hangzhou Clongene Biotech
3.8.1 Hangzhou Clongene Biotech Information
3.8.2 Hangzhou Clongene Biotech Overview
3.8.3 Hangzhou Clongene Biotech COVID-19 Rapid Antigen Test Revenue and Gross Margin (2019-2024)
3.8.4 Hangzhou Clongene Biotech Related Developments
3.9 Healgen Scientific Limited
3.9.1 Healgen Scientific Limited Information
3.9.2 Healgen Scientific Limited Overview
3.9.3 Healgen Scientific Limited COVID-19 Rapid Antigen Test Revenue and Gross Margin (2019-2024)
3.9.4 Healgen Scientific Limited Related Developments
3.10 LumiraDX UK Ltd.
3.10.1 LumiraDX UK Ltd. Information
3.10.2 LumiraDX UK Ltd. Overview
3.10.3 LumiraDX UK Ltd. COVID-19 Rapid Antigen Test Revenue and Gross Margin (2019-2024)
3.10.4 LumiraDX UK Ltd. Related Developments
3.11 Quidel Corporation
3.11.1 Quidel Corporation Information
3.11.2 Quidel Corporation Overview
3.11.3 Quidel Corporation COVID-19 Rapid Antigen Test Revenue and Gross Margin (2019-2024)
3.11.4 Quidel Corporation Related Developments
3.12 SD BIOSENSOR, Inc.
3.12.1 SD BIOSENSOR, Inc. Information
3.12.2 SD BIOSENSOR, Inc. Overview
3.12.3 SD BIOSENSOR, Inc. COVID-19 Rapid Antigen Test Revenue and Gross Margin (2019-2024)
3.12.4 SD BIOSENSOR, Inc. Related Developments
3.13 Roche
3.13.1 Roche Information
3.13.2 Roche Overview
3.13.3 Roche COVID-19 Rapid Antigen Test Revenue and Gross Margin (2019-2024)
3.13.4 Roche Related Developments
3.14 Siemens Healthineers
3.14.1 Siemens Healthineers Information
3.14.2 Siemens Healthineers Overview
3.14.3 Siemens Healthineers COVID-19 Rapid Antigen Test Revenue and Gross Margin (2019-2024)
3.14.4 Siemens Healthineers Related Developments
3.15 Xiamen Boson Biotech Co.
3.15.1 Xiamen Boson Biotech Co. Information
3.15.2 Xiamen Boson Biotech Co. Overview
3.15.3 Xiamen Boson Biotech Co. COVID-19 Rapid Antigen Test Revenue and Gross Margin (2019-2024)
3.15.4 Xiamen Boson Biotech Co. Related Developments
3.16 Zhejiang Orient Gene Biotech Co., Ltd.
3.16.1 Zhejiang Orient Gene Biotech Co., Ltd. Information
3.16.2 Zhejiang Orient Gene Biotech Co., Ltd. Overview
3.16.3 Zhejiang Orient Gene Biotech Co., Ltd. COVID-19 Rapid Antigen Test Revenue and Gross Margin (2019-2024)
3.16.4 Zhejiang Orient Gene Biotech Co., Ltd. Related Developments
4 Market Size by Type
4.1 Global COVID-19 Rapid Antigen Test Revenue by Type
4.2 Global COVID-19 Rapid Antigen Test Market Size Growth by Type 2019-2024
5 Market Size by Application
5.1 Global COVID-19 Rapid Antigen Test Revenue by Application
5.2 Global COVID-19 Rapid Antigen Test Market Size Growth by Application 2019-2024
6 Global COVID-19 Rapid Antigen Test Market Insights
6.1 Global COVID-19 Rapid Antigen Test Market Revenue 2019-2024
6.2 Global COVID-19 Rapid Antigen Test Revenue by Region
6.3 Americas
6.4 Europe
6.5 Asia-Pacific
6.6 Middle East & Africa
7 Americas
7.1 Americas COVID-19 Rapid Antigen Test Market Size by Country
7.1.1 Americas COVID-19 Rapid Antigen Test Revenue by Country (2019-2024)
7.1.2 U.S.
7.1.3 Canada
7.1.4 Mexico
7.1.5 Brazil
7.1.6 Argentina
8 Europe
8.1 Europe COVID-19 Rapid Antigen Test Market Size by Country
8.1.1 Europe COVID-19 Rapid Antigen Test Revenue by Country (2019-2024)
8.1.2 Germany
8.1.3 France
8.1.4 U.K.
8.1.5 Italy
8.1.6 Russia
9 Asia Pacific
9.1 Asia Pacific COVID-19 Rapid Antigen Test Market Size by Region
9.1.1 Asia Pacific COVID-19 Rapid Antigen Test Revenue by Region (2019-2024)
9.1.2 China
9.1.3 Japan
9.1.4 South Korea
9.1.5 India
9.1.6 Southeast Asia
9.1.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa COVID-19 Rapid Antigen Test Market Size by Country
10.1.1 Middle East and Africa COVID-19 Rapid Antigen Test Revenue by Country (2019-2024)
10.1.2 Turkey
10.1.3 Saudi Arabia
10.1.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 COVID-19 Rapid Antigen Test Industry Trends
11.2 COVID-19 Rapid Antigen Test Market Drivers
11.3 COVID-19 Rapid Antigen Test Market Challenges
11.4 COVID-19 Rapid Antigen Test Market Restraints
12 COVID-19 Rapid Antigen Test Forecasted Market Size by Type
12.1 Global COVID-19 Rapid Antigen Test Forecasted Revenue by Type
12.2 Global COVID-19 Rapid Antigen Test Forecasted Market Size Growth by Type 2024-2030
13 COVID-19 Rapid Antigen Test Forecasted Market Size by Application
13.1 Global COVID-19 Rapid Antigen Test Forecasted Revenue by Application
13.2 Global COVID-19 Rapid Antigen Test Forecasted Market Size Growth by Application 2024-2030
14 Global COVID-19 Rapid Antigen Test Market Forecasts
14.1 Global COVID-19 Rapid Antigen Test Market Revenue Forecasts 2024-2030
14.2 Global COVID-19 Rapid Antigen Test Forecasts Revenue by Region
14.3 Americas
14.4 Europe
14.5 Asia-Pacific
14.6 Middle East & Africa
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer
List of Tables and Figures
Figure COVID-19 Rapid Antigen Test Picture
Table Product Definition of COVID-19 Rapid Antigen Test
Table Global COVID-19 Rapid Antigen Test Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
Table Global COVID-19 Rapid Antigen Test Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
Table Global COVID-19 Rapid Antigen Test Market by Region: 2019 VS 2024 VS 2030
Figure Global COVID-19 Rapid Antigen Test Revenue Market Size & Forecasts 2019-2030
Figure Years Considered
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global COVID-19 Rapid Antigen Test Revenue by Players (2019-2024)
Table Global COVID-19 Rapid Antigen Test Revenue Market Share by Players (2019-2024)
Figure Top 5 Largest Players of COVID-19 Rapid Antigen Test in 2024
Figure Top 10 Largest Players of COVID-19 Rapid Antigen Test in 2024
Table Global COVID-19 Rapid Antigen Test Gross Margin by Players
Table Players Market Concentration Ratio (CR5)
Table Global COVID-19 Rapid Antigen Test Players Geographical Distribution
Table Mergers & Acquisitions, Expansion Plans
Table Company Profiles
Table Abbott Overview
Table Abbott Revenue, Gross, Gross Margin 2019-2024
Table Abbott Related Developments
Table Company Profiles
Table Cipla Overview
Table Cipla Revenue, Gross, Gross Margin 2019-2024
Table Cipla Related Developments
Table Company Profiles
Table AMEDA Labordiagnostik GmbH Overview
Table AMEDA Labordiagnostik GmbH Revenue, Gross, Gross Margin 2019-2024
Table AMEDA Labordiagnostik GmbH Related Developments
Table Company Profiles
Table Becton Dickinson Overview
Table Becton Dickinson Revenue, Gross, Gross Margin 2019-2024
Table Becton Dickinson Related Developments
Table Company Profiles
Table Beijing Lepu Medical Technology Overview
Table Beijing Lepu Medical Technology Revenue, Gross, Gross Margin 2019-2024
Table Beijing Lepu Medical Technology Related Developments
Table Company Profiles
Table BIOSYNEX SWISS SA Overview
Table BIOSYNEX SWISS SA Revenue, Gross, Gross Margin 2019-2024
Table BIOSYNEX SWISS SA Related Developments
Table Company Profiles
Table CerTest Biotect S.L. Overview
Table CerTest Biotect S.L. Revenue, Gross, Gross Margin 2019-2024
Table CerTest Biotect S.L. Related Developments
Table Company Profiles
Table Hangzhou Clongene Biotech Overview
Table Hangzhou Clongene Biotech Revenue, Gross, Gross Margin 2019-2024
Table Hangzhou Clongene Biotech Related Developments
Table Company Profiles
Table Healgen Scientific Limited Overview
Table Healgen Scientific Limited Revenue, Gross, Gross Margin 2019-2024
Table Healgen Scientific Limited Related Developments
Table Company Profiles
Table LumiraDX UK Ltd. Overview
Table LumiraDX UK Ltd. Revenue, Gross, Gross Margin 2019-2024
Table LumiraDX UK Ltd. Related Developments
Table Company Profiles
Table Quidel Corporation Overview
Table Quidel Corporation Revenue, Gross, Gross Margin 2019-2024
Table Quidel Corporation Related Developments
Table Company Profiles
Table SD BIOSENSOR, Inc. Overview
Table SD BIOSENSOR, Inc. Revenue, Gross, Gross Margin 2019-2024
Table SD BIOSENSOR, Inc. Related Developments
Table Company Profiles
Table Roche Overview
Table Roche Revenue, Gross, Gross Margin 2019-2024
Table Roche Related Developments
Table Company Profiles
Table Siemens Healthineers Overview
Table Siemens Healthineers Revenue, Gross, Gross Margin 2019-2024
Table Siemens Healthineers Related Developments
Table Company Profiles
Table Xiamen Boson Biotech Co. Overview
Table Xiamen Boson Biotech Co. Revenue, Gross, Gross Margin 2019-2024
Table Xiamen Boson Biotech Co. Related Developments
Table Company Profiles
Table Zhejiang Orient Gene Biotech Co., Ltd. Overview
Table Zhejiang Orient Gene Biotech Co., Ltd. Revenue, Gross, Gross Margin 2019-2024
Table Zhejiang Orient Gene Biotech Co., Ltd. Related Developments
Table Global COVID-19 Rapid Antigen Test Revenue by Type (2019-2024)
Table Global COVID-19 Rapid Antigen Test Revenue Share by Type (2019-2024)
Table Global COVID-19 Rapid Antigen Test Revenue by Application (2019-2024)
Table Global COVID-19 Rapid Antigen Test Revenue Share by Application (2019-2024)
Figure Global COVID-19 Rapid Antigen Test Market Revenue 2019-2024
Table Global COVID-19 Rapid Antigen Test Revenue by Region (2019-2024)
Table Global COVID-19 Rapid Antigen Test Revenue Share by Region (2019-2024)
Figure Americas COVID-19 Rapid Antigen Test Revenue (2019-2024)
Figure Europe COVID-19 Rapid Antigen Test Revenue (2019-2024)
Figure Asia-Pacific COVID-19 Rapid Antigen Test Revenue (2019-2024)
Figure Middle East & Africa COVID-19 Rapid Antigen Test Revenue (2019-2024)
Table Americas COVID-19 Rapid Antigen Test Revenue by Country (2019-2024)
Table Americas COVID-19 Rapid Antigen Test Revenue Share by Country (2019-2024)
Figure United States COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Figure Canada COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Figure Mexico COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Figure Brazil COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Figure Argentina COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Table Europe COVID-19 Rapid Antigen Test Revenue by Country (2019-2024)
Table Europe COVID-19 Rapid Antigen Test Revenue Share by Country (2019-2024)
Figure Germany COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Figure France COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Figure U.K. COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Figure Italy COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Figure Russia COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Table Asia Pacific COVID-19 Rapid Antigen Test Revenue by Region (2019-2024)
Table Asia Pacific COVID-19 Rapid Antigen Test Revenue Share by Region (2019-2024)
Figure China COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Figure Japan COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Figure South Korea COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Figure India COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Figure Southeast Asia COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Figure Australia COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Table Middle East and Africa COVID-19 Rapid Antigen Test Revenue by Country (2019-2024)
Table Middle East and Africa COVID-19 Rapid Antigen Test Revenue Share by Country (2019-2024)
Figure Turkey COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Figure Saudi Arabia COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Figure U.A.E COVID-19 Rapid Antigen Test Revenue Market Size (2019-2024)
Table Global COVID-19 Rapid Antigen Test Forecasted Revenue by Type (2019-2024)
Table Global COVID-19 Rapid Antigen Test Forecasted Revenue Share by Type (2019-2024)
Table Global COVID-19 Rapid Antigen Test Forecasted Revenue by Application (2019-2024)
Table Global COVID-19 Rapid Antigen Test Forecasted Revenue Share by Application (2019-2024)
Figure Global COVID-19 Rapid Antigen Test Market Revenue Forecasts 2024-2030
Table Global COVID-19 Rapid Antigen Test Forecasts Revenue by Region (2024-2030)
Table Global COVID-19 Rapid Antigen Test Forecasts Revenue Share by Region (2024-2030)
Figure Americas COVID-19 Rapid Antigen Test Forecasts Revenue and Growth (2024-2030)
Figure Europe COVID-19 Rapid Antigen Test Forecasts Revenue and Growth (2024-2030)
Figure Asia-Pacific COVID-19 Rapid Antigen Test Forecasts Revenue and Growth (2024-2030)
Figure Middle East & Africa COVID-19 Rapid Antigen Test Forecasts Revenue and Growth (2024-2030)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report